---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-26-000100"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T17:20:08.042630+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Encompass Health enters $1B revolver with Truist; matures 2031, replaces 2022 facility

## Summary
- New $1.0B revolving credit facility with Truist Bank as administrative agent; maturity extended to March 9, 2031 (from Oct 2027).
- Undrawn commitment fee reduced by 5 bps; swingline sublimit increased to $40M (from $25M); 0.10% SOFR adjustment eliminated.
- Drew $250M to repay prior credit agreement; also drew $53.6M on new letter of credit subfacility.
- Financial covenants: minimum Interest Coverage Ratio 3.00x; maximum Leverage Ratio 4.50x (net of cash), except for significant acquisitions.
- Accordion permits up to $1.4B or 100% EBITDA additional commitments, subject to Senior Secured Leverage Ratio ≤ 3.50x.

## SEC filing metadata
- accession: 0000785161-26-000100
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/0000785161-26-000100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/ehc-20260309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-26-000100
- JSON: https://secwatch.observer/filing/0000785161-26-000100.json
- Plain text: https://secwatch.observer/filing/0000785161-26-000100.txt

## Source-grounded claims
- claim_id: c6dc90e533bd4291efd359b86fdd1abc2f0e6f8c
  claim: Encompass Health Corp incurred revolving credit of $1 billion with Truist Bank at SOFR plus 3.00% maturing March 9, 2031.
  evidence_excerpt: On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/0000785161-26-000100-index.htm
- claim_id: 2c9337124353fc222b53e6749ec44e8dda230793
  claim: Encompass Health Corp entered into 2026 Collateral and Guarantee Agreement with Truist Bank, as collateral agent (effective 2026-03-09).
  evidence_excerpt: Additionally, the Company terminated its existing collateral and guarantee agreement with Barclays and entered into the Collateral and Guarantee Agreement (the “2026 Collateral and Guarantee Agreement”), by and among the Company, certain of its subsidiaries, and Truist Bank, as collateral agent, which provides for similar terms in all material respects.
  evidence_url: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/0000785161-26-000100-index.htm
- claim_id: 33e9c8de2ea4458f03ba60f95e740e5c9bb50b36
  claim: Encompass Health Corp entered into 2026 Credit Agreement with Truist Bank, as administrative agent and collateral agent, and various other lenders valued at $1 billion (effective 2026-03-09).
  evidence_excerpt: On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/0000785161-26-000100-index.htm
- claim_id: 7cf160a64f7b4a0c7b4be8588e5bce1791ac2c0d
  claim: Encompass Health Corp terminated 2022 Credit Agreement with Barclays Bank PLC, as administrative agent and collateral agent, and various other lenders (effective 2026-03-09).
  evidence_excerpt: As disclosed in Item 1.01 of this Current Report on Form 8-K, on March 9, 2026, the Company terminated the 2022 Credit Agreement and the Second Amended and Restated Collateral and Guarantee Agreement, dated November 25, 2019, by and among the Company, certain of its subsidiaries, and Barclays, as collateral agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/785161/000078516126000100/0000785161-26-000100-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.